Cardiology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Looking for a medical communications company? MedWrite International specializes in delivering global strategic medical marketing communications. Visit MedWrite's site to learn more.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 6.
Incidence of High Cholesterol Drops in U.S.
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Incidence of High Cholesterol Drops in U.S.Category: Health NewsCreated: 11/17/2009 4:10:00 PMLast Editorial Review: 11/18/2009
Source: MedicineNet Heart General - November 18, 2009 Category: Cardiology Source Type: consumer
Heartburn Drugs Can Thwart Popular Blood ThinnerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Heartburn Drugs Can Thwart Popular Blood ThinnerCategory: Health NewsCreated: 11/17/2009 4:10:00 PMLast Editorial Review: 11/18/2009
Source: MedicineNet Heart General - November 18, 2009 Category: Cardiology Source Type: consumer
Obesity Rolling Back Gains in Heart HealthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Obesity Rolling Back Gains in Heart HealthCategory: Health NewsCreated: 11/17/2009 4:10:00 PMLast Editorial Review: 11/18/2009
Source: MedicineNet Heart General - November 18, 2009 Category: Cardiology Source Type: consumer
Heart Failure Drug May Help More in Higher DosesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Heart Failure Drug May Help More in Higher DosesCategory: Health NewsCreated: 11/17/2009 6:10:00 PMLast Editorial Review: 11/18/2009
Source: MedicineNet Heart General - November 18, 2009 Category: Cardiology Source Type: consumer
New Heart Attack Treatment Guidelines Stress CoordinationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: New Heart Attack Treatment Guidelines Stress CoordinationCategory: Health NewsCreated: 11/18/2009 8:10:00 AMLast Editorial Review: 11/18/2009
Source: MedicineNet Heart General - November 18, 2009 Category: Cardiology Source Type: consumer
Incidence of High Cholesterol Drops in U.S.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Incidence of High Cholesterol Drops in U.S.Category: Health NewsCreated: 11/17/2009 4:10:00 PMLast Editorial Review: 11/18/2009
Source: MedicineNet High Blood Pressure General - November 18, 2009 Category: Cardiology Source Type: consumer
Obesity Rolling Back Gains in Heart HealthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Obesity Rolling Back Gains in Heart HealthCategory: Health NewsCreated: 11/17/2009 4:10:00 PMLast Editorial Review: 11/18/2009
Source: MedicineNet High Blood Pressure General - November 18, 2009 Category: Cardiology Source Type: consumer
Merck Announces Completion Of Patient Enrollment In Phase III Trial Of SCH 530348, A Novel, Oral Antiplatelet PAR-1 InhibitorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merck announced the completion of patient enrollment in the TRA 2°P-TIMI 50 clinical trial, a Phase III, randomized, double-blind, placebo-controlled, multinational study of SCH 530348, the company's investigational antiplatelet protease activated receptor-1 (PAR-1) inhibitor. The study, conducted by the Thrombolysis in Myocardial Infarction (TIMI) Study Group, reached its target of more than 26,000 patients.
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
JAMA: Cholesterol guidelines need to be simplifiedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Between 1999 and 2006, the prevalence of U.S. adults with high levels of LDL cholesterol decreased by about one-third, according to a study published Nov. 18 in the Journal of the American Medical Association. However, a high percentage of adults still are not being screened or treated for high cholesterol levels.
Source: Cardiovascular Business News - November 18, 2009 Category: Cardiology Tags: Latest News Source Type: news
Characterisation of heart failure with normal ejection fraction in a tertiary hospital in NigeriaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Background:
The study aimed to determine the frequency and characteristics of heart failure with normal EF in a native African population with heart failure.
Methods:
It was a hospital-based study. Subjects were 177 consecutive individuals with heart failure and ninety apparently normal control subjects. All the subjects underwent transthoracic echocardiography. The group with heart failure was further subdivided into heart failure with normal EF (EF [greater than or equal to]50) (HFNEF) and heart failure with low EF(EF
Source: BMC Cardiovascular Disorders - November 18, 2009 Category: Cardiology Authors: Adedeji AdebayoAdewole AdebiyiOlulola OladapoOkechukwu OgahAkinyemi AjeDike OjjiAyodele Falase Source Type: journals
An Anterior Ablation Line Is Preferred for Perimitral Flutter After Heart TransplantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We report 2 cases where an anterior ablation line was easily performed to eliminate perimitral flutter and produce bidirectional block. (J Cardiovasc Electrophysiol, Vol. pp. 1[ndash]3)
Source: Journal of Cardiovascular Electrophysiology - November 18, 2009 Category: Cardiology Authors: BHAVANESH MAKANJEE, GEORGE J. KLEIN, NICHOLAS DERVAL, ALLAN C. SKANES Source Type: journals
Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Background:
Resistin, secreted from adipocytes, causes insulin resistance in mice. The relationship between resistin and coronary artery disease is highly controversial, and the information regarding resistin and ischemic stroke is limited. In the present study, the association between serum resistin concentration and cardiovascular disease (CVD) was investigated in a general Japanese population.
Methods:
A total of 3,201 community-dwelling individuals aged 40 years or older (1,382 men and 1,819 women) were divided into quintiles of serum resistin, and the association between resistin and CVD was examined cross-sectionally...
Source: Cardiovascular Diabetology - November 18, 2009 Category: Cardiology Authors: Haruhiko OsawaYasufumi DoiHideichi MakinoToshiharu NinomiyaKoji YonemotoRyoichi KawamuraJun HataYumihiro TanizakiMitsuo IidaYutaka Kiyohara Source Type: journals
Does "Hidden Undercuffing" Occur Among Obese Patients? Effect of Arm Sizes and Other Predictors of the Difference Between Wrist and Upper Arm Blood PressuresEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
J Clin Hypertens (Greenwich). Arm size can affect the accuracy of blood pressure (BP) measurement, and "undercuffing" of large upper arms is likely to be a growing problem. Therefore, the authors investigated the relationship between upper arm and wrist readings. Upper arm and wrist circumferences and BP were measured in 261 consecutive patients. Upper arm auscultation and wrist BP was measured in triplicate, rotating measurements every 30 seconds between sites. Upper arm BP was 131.9±20.6/71.6±12.6 mm Hg in an obese population (body mass index, 30.6±6.6 kg/m2) with mean upper arm size of 30.7±5.1 cm. Wrist BP was high...
Source: The Journal of Clinical Hypertension - November 18, 2009 Category: Cardiology Authors: Hardik Doshi, Alan B. Weder, Robert L. Bard, Robert D. Brook Source Type: journals
High-dose versus low-dose losartan in patients with heart failure (HEAAL study)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Lancet
Area: News
According to the results of an international, multicentre study reported at the American Heart Association Scientific Session 2009 and published early online in the Lancet, the use of a higher dose of losartan (150mg daily) improves clinical outcomes in patients with heart failure compared to a lower dose (50mg daily), in patients with heart failure and intolerance to ACE inhibitors (ACEI).
The authors note that clinical trials of angiotensin-receptor blockers (ARBs), given with or without ACEI in heart failure, have not explored the relationship between dose of ARB and clinical ...
Source: NeLM - Cardiovascular Medicine - November 18, 2009 Category: Cardiology Source Type: organizations
Ferric carboxymaltose in patients with heart failure and iron deficiencyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: NEJM
Area: News
According to the results of a RCT published early online in the New England Journal of Medicine, treating chronic heart failure patients who have iron deficiency with IV iron (ferric carboxymaltose; Ferinject®) improves symptoms, functional capacity, and quality of life.
A total of 459 patients with NYHA class II or III chronic heart failure were enrolled in the Ferinject Assessment in Patients with Iron Deficiency and Chronic Heart Failure (FAIR-HF) trial. All had a LVEF ?40% (if class II) or ?45% (if class III), iron deficiency (ferritin level <100 mcg/L, or 100-299 mcg/L if ...
Source: NeLM - Cardiovascular Medicine - November 18, 2009 Category: Cardiology Source Type: organizations
Commentary: Reconsidering the role for digoxin in the management of acute heart failure syndromesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: JAMA
Area: News
This Commentary article in JAMA discusses how the use of digoxin in the treatment of patients with chronic heart failure has decreased considerably, and argues that it is time to 'remember a forgotten drug'.
Digoxin was licensed for this use based on the results of the Digitalis Investigation Group trial, which found that it reduced hospitalisations when added to standard therapy (diuretics and ACE inhibitors), although there was no effect on survival. Available data suggest that digoxin use has decreased considerably in the last 10 years; the author postulates several factor...
Source: NeLM - Cardiovascular Medicine - November 18, 2009 Category: Cardiology Source Type: organizations
FAIR-HF: Intravenous iron improves chronic heart failure outcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Intravenous iron treatment improves multiple clinical outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction, regardless of whether or not they also have anemia, according to data from the FAIR-HF study.
Source: MedWire News - Cardiology - November 18, 2009 Category: Cardiology Source Type: news
HeartMate II: Continuous-flow left ventricular assist device outperforms pulsatile-flow device in advanced heart failureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A continuous-flow left ventricular assist device achieved superior outcomes to a pulsatile-flow LVAD in patients with advanced heart failure. In the HeartMate II Destination Therapy clinical trial, 2-year survival for patients implanted with the continuous-flow device was more than double that of patients implanted with the pulsatile-flow device.
Source: MedWire News - Cardiology - November 18, 2009 Category: Cardiology Source Type: news
Is Surface ECG a Useful Surrogate for Subcutaneous ECG?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion: Surface ECGs are adequate surrogates for subcutaneous ECGs in situations free from motion artifacts but not in situations involving movement of the device, surface electrodes, or recording equipment. During artifact-inducing maneuvers, subcutaneous ECGs are of higher quality and less susceptible to artifacts than surface ECGs. (PACE 2009; 1[ndash]11)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: CARISSA L. BELLARDINE BLACK, KURT STROMBERG, GEORGETTE PLEMPER VAN BALEN, RAJA N. GHANEM, ROBERT W. BREEDVELD, ROBERT G. TIELEMAN Source Type: journals
Psychopathology in Patients with ICDs over Time: Results of a Prospective StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:Patients receiving ICDs have significant rates of baseline psychopathology after implantation. However, psychological assessment scores tend to improve with time. ICD shocks do not appear to significantly impact psychological state. These results suggest the importance of close screening and referral for possible psychopathology in patients receiving ICDs, especially in the peri-implant period. (PACE 2009; 1[ndash]11)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: SURAJ KAPA, DEBRA ROTONDI-TREVISAN, ZANA MARIANO, THERESA AVES, JANE IRVINE, PAUL DORIAN, DAVID L. HAYES Source Type: journals
The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia PacingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion:ATP delivered from a LCV lead offers no efficacy advantage over pacing from the RVA. (PACE 2009; 1[ndash]6)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: RAYMOND YEE, ULRIKA BIRGERSDOTTER-GREEN, PAUL BELK, TROY JACKSON, JILL CHRISTENSEN, MARK S. WATHEN Source Type: journals
Determining Arrhythmia Mechanism: Still Critical or Now Obsolete?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: FRANK C. CHEN, SAMUEL J. ASIRVATHAM Source Type: journals
Mapping and Isolation of the Pulmonary Veins Using the PVAC CatheterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:(1) PVAC-guided ablation (i.e., mapping and ablation with a single catheter) results in isolation of all PVs in 73% of the patients. (2) An additional circular mapping catheter is required to increase complete isolation rate to 93% of the patients. (3) Given the esophageal T° rise in almost 50% of patients, safety precautions are needed. (PACE 2009; 1[ndash]11)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: MATTIAS DUYTSCHAEVER, WIM ANNE, GIORGI PAPIASHVILI, YVES VANDEKERCKHOVE, RENE TAVERNIER Source Type: journals
Journal Scan: Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness (N Engl J Med 2009;Nov 15:[Epub ahead of print].)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In the ARBITER 6-HALTS trial, patients with coronary heart disease or a coronary heart disease risk equivalent, who were receiving long-term statin therapy, with a low-density lipoprotein (LDL) cholesterol under 100 mg/dl and a high-density lipoprotein (HDL) cholesterol under 50 mg/dl for men or 55 . . .
Source: Cardiosource - November 18, 2009 Category: Cardiology Source Type: organizations
Expert Opinion: CCA Focus: Palliative Care in Congestive Heart FailureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Cardiosource - November 18, 2009 Category: Cardiology Source Type: organizations
Radiofrequency Catheter Ablation of Atrial Tachycardia Under Navigation Using the EnSite Array.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions: EA-guided RFA is safe and effective for AT, irrespective of its mechanism, sustainability or origin, and regardless of underlying heart disease.
PMID: 19920360 [PubMed - as supplied by publisher]
Source: Circulation Journal - November 18, 2009 Category: Cardiology Authors: Narita S, Miyamoto K, Tsuchiya T, Nagamoto Y, Yamaguchi T Tags: Circ J Source Type: journals
Three-Dimensional Electroanatomic Mapping Systems in Catheter Ablation of Atrial Fibrillation.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Atrial fibrillation (AF) is the most common tachyarrhythmia, with a prevalence of 5% in people over the age of 65. Catheter ablation of AF has emerged as an important management choice for drug-refractory symptomatic paroxysmal or persistent AF. Three-dimensional (3D) electroanatomic mapping systems were introduced into catheter ablation of AF more than a decade ago. The 3D tool has the benefit of reducing the radiation exposure time, as well as voltage and fractionation mapping in order to identify the critical substrate during the ablation, prevent the formation of gaps, guide the ablation of post-ablation atrial tac...
Source: Circulation Journal - November 18, 2009 Category: Cardiology Authors: Lo LW, Chen SA Tags: Circ J Source Type: journals
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMID: 19923169 [PubMed - as supplied by publisher]
Source: Circulation - November 18, 2009 Category: Cardiology Authors: Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO Tags: Circulation Source Type: journals
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Cornonary Disease: The ONSET/OFFSET Study.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Ticagrelor achieved more rapid and greater platelet inhibition than high-loading-dose clopidogrel; this was sustained during the maintenance phase and was faster in offset after drug discontinuation. Clinical Trial Registration Information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00528411.
PMID: 19923168 [PubMed - as supplied by publisher]
Source: Circulation - November 18, 2009 Category: Cardiology Authors: Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF Tags: Circulation Source Type: journals
Happy birthday Richard Bing!Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Content Type Journal ArticleCategory LaudatioDOI 10.1007/s00392-009-0086-1Authors
Martin Gottwik, Institut für Herzinfarktforschung Bremserstr. 79 67063 Ludwigshafen Germany
Journal Clinical Research in CardiologyOnline ISSN 1861-0692Print ISSN 1861-0684
Source: Clinical Research in Cardiology - November 17, 2009 Category: Cardiology Tags: Clinical Research in Cardiology Source Type: journals
Anaemia is an independent predictor of death in patients hospitalized for acute heart failureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion Anaemia is a frequent co-morbidity in patients with acute heart failure. Moderate to severe anaemia is an independent predictor
of death in these patients.
Content Type Journal ArticleCategory Original PaperDOI 10.1007/s00392-009-0092-3Authors
Stephan von Haehling, Charité Medical School Applied Cachexia Research, Department of Cardiology Campus Virchow-Klinikum, Augustenburger Platz 1 13353 Berlin GermanyJoerg C. Schefold, Charité Medical School Department of Nephrology and Intensive Care Medicine Campus Virchow-Klinikum Berlin GermanyLea Majc Hodoscek, General Hospital Murska Sobota Depa...
Source: Clinical Research in Cardiology - November 17, 2009 Category: Cardiology Tags: Clinical Research in Cardiology Source Type: journals
Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fractionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Content Type Journal ArticleCategory Clinical CorrespondenceDOI 10.1007/s00392-009-0093-2Authors
Dirk Prochnau, Friedrich Schiller University Department of Internal Medicine I Erlanger Allee 101 07747 Jena GermanyRalf Surber, Friedrich Schiller University Department of Internal Medicine I Erlanger Allee 101 07747 Jena GermanyHelmut Kuehnert, Friedrich Schiller University Department of Internal Medicine I Erlanger Allee 101 07747 Jena GermanyMatthias Heinke, Friedrich Schiller University Department of Internal Medicine I Erlanger Allee 101 07747 Jena GermanyHelmut U. Klein, University of Rochester Medical Center Heart R...
Source: Clinical Research in Cardiology - November 17, 2009 Category: Cardiology Tags: Clinical Research in Cardiology Source Type: journals
Abbott Announces Positive Three-Year Data On Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced three-year data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries. Patients in this first phase of the ABSORB trial experienced no stent thrombosis (blood clots) out to three years and no new major adverse cardiac events (MACE1) between six months and three years (3.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
CDC data show LDL screening rate remains stagnant; many who could benefit go without lipid-lowering drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Editorialists discuss simplifying LD-management guidelines in light of a CDC study in which two-thirds of subjects who are at high risk for developing coronary disease within 10 years and eligible for lipid-lowering drugs were not on the medication.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
JACC: For mitral regurgitation, 3D echo passes the litmus testEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In a head-to-head comparison with velocity-encoded cardiac MR to measure mitral regurgitation, real-time 3D echocardiography proved feasible and accurate. In addition, researchers found that the currently recommended 2D echo approach significantly underestimated both the effective regurgitant orifice area and the regurgitant volume.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
RE-LY: Post hoc analysis confirms benefit of dabigatran relative to warfarin at all INR levelsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new analysis confirms that regardless of INR control achieved across participating centers, dabigatran remained noninferior at the lower dose and superior at the higher dose to warfarin for prevention of stroke and systemic embolism.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
Cardiologists shocked by new FDA alert on clopidogrel-PPI interactionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA has issued a new warning on an interaction between clopidogrel and the PPI omeprazole and other drugs that inhibit the CYP2C19 enzyme, just weeks after the only randomized trial on this issue reported no such interaction.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
AHA: Mummies Show Evidence of Vascular Disease (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Clogged arteries were around long before fast food restaurants dotted the world map and obesity became epidemic, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Abbott gains access to BG Medicine biomarkerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott and BG Medicine will partner to develop galectin-3, a protein that advances cardiac fibrosis, to better understand the evolution of heart failure.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
Merck to strengthen work for cardio healthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Subsequent to the completed $41 billion merger with Schering-Plough, Merck said today that it will continue its research to expand and market treatments for cardiovascular disorders.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
Statins do not eliminate risk of low HDL-cholesterol levelsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers say a new study shows that statins don't alter the risks associated with low HDL-cholesterol levels and that raising HDL cholesterol 10 mg/dL could prevent an additional eight MIs per 1000 patient-years.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
'Bad' Cholesterol Rates Plummet (CME/CE, with video)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The percentage of Americans with high levels of low-density lipoprotein (LDL) cholesterol dropped by one-third between 2000 and 2006, but screening rates remained suboptimal, researchers said.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Women Suffering Sudden Cardiac Arrest Have Lower Prevalence Of Structural Heart Disease Compared To MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A woman who suffers sudden cardiac arrest is significantly less likely than a man to exhibit the decrease in the heart's pumping ability that is widely recognized as a precursor, says a new study in the Nov. 24 Journal of the American College of Cardiology. The lack of left ventricular dysfunction could mean that fewer women meet current medical guidelines for implantable cardiac defibrillators that can prevent sudden cardiac arrest, says the study's lead researcher.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
AHA: Accident Kills Noted CardiologistEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- A Harvard cardiologist was killed here Monday when he was hit by a car while jogging. Kenneth Baughman, MD, 63, director of the advanced heart disease program at Brigham and Women's Hospital, was attending the American Heart Association meeting.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Kenneth Baughman killed while jogging at AHAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr Kenneth Baughman, a cardiologist at Brigham and Women's Hospital, died Monday morning in Orlando, FL, when he was struck by a car while out for a morning run.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
AHA: FDA Drops Clopidogrel Bomb at AHAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, thus increasing the risk of myocardial infarction and stroke.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
AHA: Active Video Games Can Break a Sweat (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Active video games such as Wii Sports or Wii Fit may provide the equivalent of a moderate intensity workout, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
AHA: New Trumps Old in Comparison of Heart Pumps (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- A newer-generation left ventricular assist device, HeartMate II, improved outcomes more as destination therapy for advanced heart failure than an older device, HeartMate XVE, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Anthracycline cardiotoxicity appears limited in breast cancer in the short termEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
No significant incidence of short-term cardiac toxicity was observed in breast-cancer patients on dose-dense anthracycline regimens, but longer-term follow-up is needed.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
Telephone-Delivered Care For Treating Depression After CABG Surgery Appears To Improve OutcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
